http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104937423-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96452 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6443 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate | 2013-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104937423-B |
| titleOfInvention | Method for evaluating blood coagulation reaction |
| abstract | It is attempted to establish a method for evaluating a blood coagulation reaction using a substance having an alternative activity for the activity of coagulation factor VIII (FVIII) with respect to various hemostatic effect evaluation methods and various blood coagulation initiation reagents. As a result, it is found that, when a coagulation initiation reagent comprising activated coagulation factor XI (FXIa) and a phospholipid is used, the effect of a substance having an alternative activity for the activity of coagulation factor VIII (FVIII) on a blood coagulation reaction can be evaluated employing the amount of thrombin produced in a blood sample as a measure. |
| priorityDate | 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.